LMTK2 and prostate adenocarcinoma: The LMTK2-AR interaction was demonstrated by co-immunoprecipitation and Proximity Ligation Assay (PLA) in LNCaP cells, an androgen-sensitive human prostate adenocarcinoma cell line.